Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety

CONTEXT: Conventional treatment of hypoparathyroidism is associated with decreased renal function and increased bone mineral density (BMD). OBJECTIVE: To evaluate the effects of 8 years of recombinant human parathyroid hormone (1-84) [rhPTH(1-84)] therapy on key biochemical and densitometric indices...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Endocrinol Metab
Asıl Yazarlar: Tay, Yu-Kwang Donovan, Tabacco, Gaia, Cusano, Natalie E, Williams, John, Omeragic, Beatriz, Majeed, Rukshana, Gomez Almonte, Maximo, Bilezikian, John P, Rubin, Mishaela R
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Endocrine Society 2019
Konular:
Clinical Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6977408/
https://ncbi.nlm.nih.gov/pubmed/31310310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2019-00893
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller